AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers

Share :
Published: 1 May 2009
Views: 17523
Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research
Daniel Von Hoff, M.D., senior investigator/physician-in-chief, TGen; chief scientific officer, Scottsdale Healthcare and U.S. Oncology Research, speaking at AACR 2009, Denver: A Pilot Study Utilizing Molecular Profiling of Tumours to Find Potential Targets and Select Treatments for Their Refractory Cancers